Insider Transactions Reported by 12 Insiders of MEDIFAST INC

Symbol
MED on NYSE
Location
Baltimore, MD

Key facts

  • MED - MEDIFAST INC has 12 insiders with reported activity on this page.
  • Net insider value flow over the last year: +$246,677.
  • Recent transaction rows are available for direct filing-level review.

Change

  • Buy value: $246,677; sell value: $0.
  • Net share flow: +23,059.

Research use

  • This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
  • Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Evidence

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Net insider flow leans to buying over the last 12 months. Net value: +$246,677.

Buys

$246,677

Shares: 23,059

Insiders: 2

Sells

$0

Shares: 0

Insiders: 0

Net

+$246,677

Shares: +23,059

Insiders: 2

Window (months) Buy shares Sell shares Buy $ Sell $ Net $
0-3 22,678 0 $241,675 $0 +$241,675
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 381 0 $5,003 $0 +$5,003

MEDIFAST INC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Daniel R. Chard Chairman & CEO, Director $3,787,830 +$183,727 +5.1% Mixed 13 Mar 2026
Kevin G. Byrnes Director $1,027,977 Mixed 11 Nov 2021
James P. Maloney Chief Financial Officer $779,992 Mixed 13 Mar 2026
Jeffrey J. Brown Director $573,487 Mixed 25 Jun 2025
Ming Xian Director $430,393 Mixed 25 Jun 2025
Scott Schlackman Director $382,775 +$62,950 +20% Filing P/S 08 May 2026
Michael A. Hoer Director $351,575 Mixed 25 Jun 2025
Andrea B. Thomas Director $323,030 Mixed 25 Jun 2025
Elizabeth A. Geary Director $262,880 Mixed 25 Jun 2025
Jonathan Barrett MacKenzie VP, Finance & CAO $222,549 Mixed 13 Mar 2026
Nicholas Mark Johnson President $195,833 Mixed 05 Jan 2026
Constance J. Hallquist Former Director $148,251 Mixed 06 Oct 2023

Top shareholders of MEDIFAST INC (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
RENAISSANCE TECHNOLOGIES LLC
13D/G 13F
Company
7%
773,710
$8,139,429 -$1,212,093 02 Jan 2026
Citadel Securities GP LLC
13D/G
6.5%
715,910
$7,531,373 $0 31 Mar 2026
Steamboat Capital Partners, LLC
13F 13D/G
Company
6%
from 13D/G
707,590
$7,210,342 31 Mar 2026
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F 13D/G
Company
5.7%
from 13D/G
631,539
$6,435,382 31 Mar 2026
SUSQUEHANNA SECURITIES, LLC
13D/G
G1 Execution Services, LLC
1.4%
148,944
$1,741,155 -$5,915,152 31 Dec 2025
Daniel R. Chard
3/4/5
Chairman & CEO, Director
3.2%
355,609
$3,787,830 +$183,727 13 Mar 2026
James P. Maloney
3/4/5
Chief Financial Officer
0.66%
73,033
$779,992 13 Mar 2026
Jeffrey J. Brown
3/4/5
Director
0.39%
42,811
$573,487 25 Jun 2025
Scott Schlackman
3/4/5
Director
0.28%
30,549
$382,775 +$62,950 08 May 2026
Michael A. Hoer
3/4/5
Director
0.24%
26,139
$351,575 25 Jun 2025
Andrea B. Thomas
3/4/5
Director
0.22%
24,017
$323,030 25 Jun 2025
Jonathan Barrett MacKenzie
3/4/5
VP, Finance & CAO
0.19%
20,838
$222,549 13 Mar 2026
Elizabeth A. Geary
3/4/5
Director
0.18%
19,545
$262,880 25 Jun 2025
BlackRock, Inc.
13F
Company
8.6%
944,453
$9,623,975 31 Mar 2026
13F
VANGUARD CAPITAL MANAGEMENT LLC
13F
Company
4%
444,467
$4,529,119 31 Mar 2026
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
3.3%
361,762
$3,686,270 31 Mar 2026
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
3.1%
338,158
$3,445,830 31 Mar 2026
13F
MORGAN STANLEY
13F
Company
3%
325,312
$3,314,942 31 Mar 2026
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.3%
253,315
$2,581,952 31 Mar 2026
13F
Man Group plc
13F
Company
2.1%
236,212
$2,407,000 31 Mar 2026
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
2%
224,280
$2,285,413 31 Mar 2026
13F
STATE STREET CORP
13F
Company
2%
222,638
$2,268,681 31 Mar 2026
13F
Peapod Lane Capital LLC
13F
Company
2%
219,063
$2,213,788 31 Mar 2026
13F
VANGUARD PORTFOLIO MANAGEMENT LLC
13F
Company
1.8%
202,829
$2,066,828 31 Mar 2026
13F
Lido Advisors, LLC
13F
Company
1.7%
183,035
$1,865,130 31 Mar 2026
13F
Trexquant Investment LP
13F
Company
1.6%
180,081
$1,835,025 31 Mar 2026
13F
D. E. Shaw & Co., Inc.
13F
Company
1.5%
160,564
$1,636,147 31 Mar 2026
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
1.4%
157,078
$1,600,625 31 Mar 2026
13F
GOLDMAN SACHS GROUP INC
13F
Company
1.4%
153,171
$1,560,812 31 Mar 2026
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
1.3%
145,575
$1,483,408 31 Mar 2026
13F
Quinn Opportunity Partners LLC
13F
Company
1.2%
127,112
$1,295,271 31 Mar 2026
13F
JANE STREET GROUP, LLC
13F
Company
1.1%
126,407
$1,288,087 31 Mar 2026
13F
NORTHERN TRUST CORP
13F
Company
0.84%
92,595
$943,544 31 Mar 2026
13F
Jump Financial, LLC
13F
Company
0.83%
90,875
$926,016 31 Mar 2026
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.81%
88,777
$904,637 31 Mar 2026
13F
JPMORGAN CHASE & CO
13F
Company
0.79%
87,178
$870,908 31 Mar 2026
13F
Divisadero Street Capital Management, LP
13F
Company
0.72%
79,839
$813,559 31 Mar 2026
13F
Virtus Family Office LLC
13F
Company
0.72%
79,060
$805,621 31 Mar 2026
13F
Empowered Funds, LLC
13F
Company
0.65%
71,584
$729,441 31 Mar 2026
13F
VANGUARD FIDUCIARY TRUST CO
13F
Company
0.61%
67,040
$683,138 31 Mar 2026
13F
FEDERATED HERMES, INC.
13F
Company
0.58%
63,921
$651,355 31 Mar 2026
13F
Atom Investors LP
13F
Company
0.55%
61,075
$622,354 31 Mar 2026
13F
Allianz Asset Management GmbH
13F
Company
0.54%
59,859
$609,963 31 Mar 2026
13F
Quantinno Capital Management LP
13F
Company
0.51%
56,153
$572,199 31 Mar 2026
13F
SummerHaven Investment Management, LLC
13F
Company
0.43%
47,835
$487,439 31 Mar 2026
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.39%
42,552
$433,603 31 Mar 2026
13F
Engineers Gate Manager LP
13F
Company
0.36%
39,580
$403,320 31 Mar 2026
13F
COMMONS CAPITAL, LLC
13F
Company
0.35%
38,000
$387,220 31 Mar 2026
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.31%
34,302
$349,537 31 Mar 2026
13F
Bank of New York Mellon Corp
13F
Company
0.31%
34,291
$349,425 31 Mar 2026
13F

Recent Insider Transactions by Companies or Individuals for MEDIFAST INC

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Scott Schlackman MED Common Stock Purchase 8.91% $31,325 $12.53 2,500 30,549 11 May 2026 Direct
Scott Schlackman MED Common Stock Purchase 9.79% $31,625 $12.65 2,500 28,049 08 May 2026 Direct
Jonathan Barrett MacKenzie MED Common Stock Award 108.2% 10,830 20,838 25 Mar 2026 Direct
Jonathan Barrett MacKenzie MED Common Stock Tax liability -7.93% -862 10,008 25 Mar 2026 Direct
James P. Maloney MED Common Stock Award 93.8% 35,358 73,033 25 Mar 2026 Direct
James P. Maloney MED Common Stock Tax liability -7.88% -3,224 37,675 25 Mar 2026 Direct
Daniel R. Chard MED Common Stock Award 28.5% 41,795 188,233 25 Mar 2026 Direct
Daniel R. Chard MED Common Stock Tax liability -12.1% -20,095 146,438 25 Mar 2026 Direct
Daniel R. Chard MED Common Stock Purchase $178,725 $10.11 17,678 17,678 20 Mar 2026 Dan and Allyson as Joint Tenants
Jonathan Barrett MacKenzie MED Common Stock Tax liability -0.64% -70 10,870 17 Mar 2026 Direct
James P. Maloney MED Common Stock Tax liability -1.16% -482 40,899 17 Mar 2026 Direct
Daniel R. Chard MED Common Stock Tax liability -1.56% -2,638 166,533 17 Mar 2026 Direct
Jonathan Barrett MacKenzie MED Common Stock Tax liability -1.78% -198 10,940 13 Mar 2026 Direct
James P. Maloney MED Common Stock Tax liability -2.17% -918 41,381 13 Mar 2026 Direct
Daniel R. Chard MED Common Stock Tax liability -4.01% -7,075 169,171 13 Mar 2026 Direct
Ming Xian MED Restricted Stock Units (cash settled) Award 114.8% 17,181 32,143 25 Jun 2025 Direct
Scott Schlackman MED Common Stock Award 77.7% 11,168 25,549 25 Jun 2025 Direct
Andrea B. Thomas MED Common Stock Award 86.9% 11,168 24,017 25 Jun 2025 Direct
Michael A. Hoer MED Common Stock Award 74.6% 11,168 26,139 25 Jun 2025 Direct
Elizabeth A. Geary MED Common Stock Award 133.3% 11,168 19,545 25 Jun 2025 Direct
Jeffrey J. Brown MED Common Stock Award 114.8% 20,617 38,578 25 Jun 2025 Direct
Daniel R. Chard MED Common Stock Purchase 0.26% $5,003 $13.13 381 149,698 13 Jun 2025 The Dan and Allyson Family Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .